CD274 and hepatocellular carcinoma: Given the mechanisms that drive PD-L1 expression on DCs in HCC patients, blocking PD-L1 on TAMs could relieve direct inhibition of effector T cells while reducing negative signaling on DCs themselves, thereby enhancing antigen presentation and co-stimulation.